The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Medical Progress
PreviousPrevious
Volume 347:417-429 August 8, 2002 Number 6
NextNext

Inflammatory Bowel Disease
Daniel K. Podolsky, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Supplementary Material
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
In the decades since the major forms of idiopathic inflammatory bowel disease were defined on the basis of clinical manifestations, investigators have been challenged to identify the fundamental pathophysiologic processes underlying these enigmatic disorders, and clinicians have struggled to provide effective therapy for the often dismaying clinical manifestations. Clinical experience has led to the generally accepted notion that Crohn's disease and ulcerative colitis are distinct, if not discrete, entities. However, whether these are fundamentally different diseases or part of a mechanistic continuum remains an unanswered question, with both conceptual and practical management implications.

Etiology and Pathophysiology

Inflammatory bowel disease is thought to result . . . [Full Text of this Article]

Genetic Factors

Environmental Precipitants and Disease Cofactors

Immune Response and Inflammatory Pathways

Treatment

5-Aminosalicylic Acid

Corticosteroids

Immunosuppressive and Immunoregulatory Agents

Anti-TNF Therapy

Antibiotics and Probiotics

Investigational Agents

Conclusions


Source Information

From the Gastrointestinal Unit and the Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, Boston.


Related Letters:

Inflammatory Bowel Disease
García de Tena J., Espinosa L. M., Alvarez-Mon M., Famularo G., Trinchieri V., De Simone C., Marchetti F., Martelossi S., Ventura A., Mohammed F., Podolsky D. K.
Extract | Full Text | PDF  
N Engl J Med 2002; 347:1982-1984, Dec 12, 2002. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.